Gene Therapy Clinical Trials
Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
The primary aim of this study is to determine whether we can identify human lung cancer tumor cells in the peripheral blood of lung cancer patients.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- procedure: phlebotomy
Eligibility
Inclusion Criteria:Inclusion Criteria:Inclusion Criteria (Cases):
1. Advanced stage (IIIB with malignant effusion or IV) histologically or cytologically
confirmed NSCLC
2. Patients must be newly diagnosed (untreated) or have evidence of disease progression
at the time of sample collection
3. ability to sign informed consent
4. at least 18 years of age
Inclusion Criteria (Controls):
1. no known prior or active malignancy
2. ability to sign informed consent
3. at least 18 years of age Exclusion Criteria:1. history of any other cancer other than
non-melanoma skin cancer within the last 5 years Exclusion Criteria:1. history of any
other cancer other than non-melanoma skin cancer within the last 5 years
2. pregnant women
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Lisa Zhou
650-736-4112
Not Recruiting